A detailed history of Voloridge Investment Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 10,767 shares of GERN stock, worth $43,283. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,767
Previous 51,982 79.29%
Holding current value
$43,283
Previous $220,000 78.18%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.17 - $4.99 $171,866 - $205,662
-41,215 Reduced 79.29%
10,767 $48,000
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $161,144 - $264,588
51,982 New
51,982 $220,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.52B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.